Lenalidomide (CC-5013)
533.48 €
533.48 €
In Stock
quantity
product details
Catalog number: 607 - A4211-250
Product Category: Business & Industrial > Science & Laboratory
Supplier:
Gentaur
Size: 250 mg
A4211-250
Lenalidomide (CC-5013)
Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects.
533.48 €
HY-108709
CC-671
CC-671 is a dual TTK protein kinase/CDC2-like kinase (CLK2) inhibitor with IC50s of 0.005 and 0.006 μM for TTK and CLK2, respectively.
1036.32 €
HY-112570
CC-90003
CC-90003 is an irreversible and selective inhibitor of ERK 1/2 with antitumor activity.
1036.32 €
HY-13022A
CC-401
CC-401 is a potent inhibitor of all three forms of JNK with Ki of 25 to 50 nM.
1742.57 €
Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects.